A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Lee Schwartzberg; Timothy Rearden; Lorrin Yee; Barry Mirtsching; Veena Charu; Hung Lam; Tom Lillie; Ronald Burkes; Peter Silberstein

A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Lee Schwartzberg
, Timothy Rearden
, Lorrin Yee
, Barry Mirtsching
, Veena Charu
, Hung Lam
, Tom Lillie
, Ronald Burkes
, Peter Silberstein

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	22-23
Number of pages	2
Journal	Journal of Supportive Oncology
Volume	5
Issue number	4 SUPPL. 2
State	Published - Apr 1 2007

Cite this

@article{0ad76ffc41fd4f4ba75bb72e3e504aab,

title = "A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia",

author = "Lee Schwartzberg and Timothy Rearden and Lorrin Yee and Barry Mirtsching and Veena Charu and Hung Lam and Tom Lillie and Ronald Burkes and Peter Silberstein",

year = "2007",

month = apr,

day = "1",

language = "English",

volume = "5",

pages = "22--23",

journal = "Journal of Supportive Oncology",

issn = "1544-6794",

number = "4 SUPPL. 2",

}

A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia. / Schwartzberg, Lee; Rearden, Timothy; Yee, Lorrin et al.
In: Journal of Supportive Oncology, Vol. 5, No. 4 SUPPL. 2, 01.04.2007, p. 22-23.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

AU - Schwartzberg, Lee

AU - Rearden, Timothy

AU - Yee, Lorrin

AU - Mirtsching, Barry

AU - Charu, Veena

AU - Lam, Hung

AU - Lillie, Tom

AU - Burkes, Ronald

AU - Silberstein, Peter

PY - 2007/4/1

Y1 - 2007/4/1

UR - https://www.scopus.com/pages/publications/34250615108

M3 - Article

AN - SCOPUS:34250615108

SN - 1544-6794

VL - 5

SP - 22

EP - 23

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

IS - 4 SUPPL. 2

ER -

A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Other files and links

Cite this